What do ELV's past earnings say about its stability?

Elevance Health (ELV) has demonstrated a generally increasing trend in net income and total revenue over the past five years, with some fluctuations. The company's diluted EPS has also shown a consistent upward trajectory, indicating a stable and growing earnings base: 1. **Growth in Net Income and Revenue**: ELV's net income has increased from $4.57 billion in 2020 to $6.15 billion in 2021, and further to $5.99 billion in 2022 and $6.15 billion in 2023, suggesting a growing profitability trend. Similarly, the total revenue has risen from $121.87 billion in 2020 to $138.64 billion in 2021, and continued to grow to $171.34 billion in 2022 and $177.01 billion in 2023. 2. **Consistent EPS Growth**: The diluted EPS has shown a steady increase from $17.98 in 2020 to $24.95 in 2021, and has continued to rise to $25.22 in 2022 and $24.95 in 2023, further reinforcing the notion of stable and growing earnings. 3. **Stability**: Despite the fluctuations in net income and revenue, the company has managed to maintain a relatively stable EPS, which is a positive indicator of its financial stability and ability to generate earnings consistently. |code|Ticker|Name|Date|Net Income (FY) YoY|Net Income (FY)|market_code| |---|---|---|---|---|---|---| |ELV|ELV.N|Elevance Health|2020|-4.888703973372166|4.572E9|169| |ELV|ELV.N|Elevance Health|2021|34.492563429571305|6.149E9|169| |ELV|ELV.N|Elevance Health|2022|-4.24459261668564|5.888E9|169| |ELV|ELV.N|Elevance Health|2023|1.749320652173913|5.991E9|169| |ELV|ELV.N|Elevance Health|2024|-0.33383408446002333|5.971E9|169| |code|Ticker|Name|Date|Total Revenue (FY)|Total Revenue (FY) YoY|market_code| |---|---|---|---|---|---|---| |ELV|ELV.N|Elevance Health|2019|1.04213E11|13.145866131046088|169| |ELV|ELV.N|Elevance Health|2020|1.21867E11|16.94030495235719|169| |ELV|ELV.N|Elevance Health|2021|1.38639E11|13.762544413171737|169| |ELV|ELV.N|Elevance Health|2022|1.56595E11|12.95162255930871|169| |ELV|ELV.N|Elevance Health|2023|1.7134E11|9.4160094511319|169| |code|Ticker|Name|Date|Diluted EPS (FY) YoY|Diluted EPS (FY)|market_code| |---|---|---|---|---|---|---| |ELV|ELV.N|Elevance Health|2019|30.16208597603946|18.47|169| |ELV|ELV.N|Elevance Health|2020|-2.652950730914989|17.98|169| |ELV|ELV.N|Elevance Health|2021|38.76529477196885|24.95|169| |ELV|ELV.N|Elevance Health|2022|-2.6853707414829584|24.28|169| |ELV|ELV.N|Elevance Health|2023|3.8714991762767617|25.22|169| In summary, ELV's past earnings performance indicates a stable and growing financial profile, with the company demonstrating the ability to increase its net income, total revenue, and diluted EPS over the past five years.